Yonghua Jing

1.3k total citations
46 papers, 802 citations indexed

About

Yonghua Jing is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Psychiatry and Mental health. According to data from OpenAlex, Yonghua Jing has authored 46 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 17 papers in Economics and Econometrics and 17 papers in Psychiatry and Mental health. Recurrent topics in Yonghua Jing's work include Atrial Fibrillation Management and Outcomes (17 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Schizophrenia research and treatment (12 papers). Yonghua Jing is often cited by papers focused on Atrial Fibrillation Management and Outcomes (17 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Schizophrenia research and treatment (12 papers). Yonghua Jing collaborates with scholars based in United States, Germany and Sweden. Yonghua Jing's co-authors include John Graham, Daniel Wiederkehr, Dinara Makenbaeva, Alpesh Amin, Edward Kim, Jay Lin, Steve Deitelzweig, Jeff J. Guo, Christina M.L. Kelton and Quynh-Van Tran and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Psychiatric Services.

In The Last Decade

Yonghua Jing

45 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yonghua Jing United States	16	278	235	188	146	146	46	802
Peter Lin Canada	13	166 0.6×	62 0.3×	98 0.5×	49 0.3×	75 0.5×	36	639
Cristina Russ United States	17	267 1.0×	74 0.3×	80 0.4×	95 0.7×	53 0.4×	56	1.8k
Julian Casciano United States	14	192 0.7×	102 0.4×	103 0.5×	59 0.4×	113 0.8×	32	566
Lotte Rasmussen Denmark	16	224 0.8×	139 0.6×	41 0.2×	68 0.5×	92 0.6×	49	752
Nicholas Dunn United Kingdom	11	148 0.5×	277 1.2×	265 1.4×	9 0.1×	42 0.3×	20	782
W Meister Germany	9	311 1.1×	94 0.4×	164 0.9×	56 0.4×	10 0.1×	32	834
Molly Tomlin United States	9	119 0.4×	97 0.4×	44 0.2×	40 0.3×	20 0.1×	9	330
Alison Evans United Kingdom	11	64 0.2×	159 0.7×	85 0.5×	10 0.1×	57 0.4×	33	707
Ewa Sucha Canada	10	124 0.4×	48 0.2×	96 0.5×	17 0.1×	17 0.1×	34	585
Juha Mehtälä Finland	15	98 0.4×	1.1k 4.9×	187 1.0×	10 0.1×	90 0.6×	48	1.6k

Countries citing papers authored by Yonghua Jing

Since Specialization

Citations

This map shows the geographic impact of Yonghua Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonghua Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonghua Jing more than expected).

Fields of papers citing papers by Yonghua Jing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonghua Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonghua Jing. The network helps show where Yonghua Jing may publish in the future.

Co-authorship network of co-authors of Yonghua Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Yonghua Jing. A scholar is included among the top collaborators of Yonghua Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonghua Jing. Yonghua Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fleurence, Rachael, Rebecca Williamson, Yonghua Jing, et al.. (2025). A Systematic Review of Augmentation Strategies for Patients with Major Depressive Disorder. Psychopharmacology Bulletin. 42(3). 57–91. 2 indexed citations

Walker, David, et al.. (2015). The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir. ClinicoEconomics and Outcomes Research. 7. 637–637. 7 indexed citations

Amin, Alpesh, Yonghua Jing, Jeffrey Trocio, et al.. (2014). Evaluation of medical costs avoided when new oral anticoagulants are used for extended treatment of venous thromboembolism based on clinical trial results. Journal of Thrombosis and Thrombolysis. 40(2). 131–138. 8 indexed citations

Amin, Alpesh, Yonghua Jing, Jeffrey Trocio, et al.. (2014). Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients. Journal of Medical Economics. 17(11). 763–770. 16 indexed citations

Amin, Alpesh, Steve Deitelzweig, Yonghua Jing, et al.. (2014). Estimation of the impact of warfarin’s time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trials. Journal of Thrombosis and Thrombolysis. 38(2). 150–159. 53 indexed citations

Deitelzweig, Steven, Erin Buysman, Brett Pinsky, et al.. (2013). Warfarin Use and Stroke Risk Among Patients With Nonvalvular Atrial Fibrillation in a Large Managed Care Population. Clinical Therapeutics. 35(8). 1201–1210. 33 indexed citations

Chang, Trina, Yonghua Jing, Albert Yeung, et al.. (2012). Effect of communicating depression severity on physician prescribing patterns: findings from the Clinical Outcomes in MEasurement-based Treatment (COMET) trial. General Hospital Psychiatry. 34(2). 105–112. 24 indexed citations

Deitelzweig, Steven, Alpesh Amin, Yonghua Jing, et al.. (2012). COMPARISON OF TOTAL MEDICAL COST AVOIDANCE WITH THE USAGE OF NEW ORAL ANTICOAGULANTS INSTEAD OF WARFARIN AMONG ATRIAL FIBRILLATION PATIENTS, BASED ON THE ARISTOTLE, RE-LY AND ROCKET-AF TRIALS. Journal of the American College of Cardiology. 59(13). E599–E599. 2 indexed citations

Gibson, Teresa B., Yonghua Jing, Zhun Cao, et al.. (2012). Impact of cost-sharing on treatment augmentation in patients with depression.. PubMed. 18(1). e15–22. 4 indexed citations

10.

Jing, Yonghua, Zhenchao Guo, Iftekhar Kalsekar, et al.. (2012). Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006–2010). International Clinical Psychopharmacology. 28(2). 87–90. 9 indexed citations

11.

Kim, Edward, et al.. (2011). One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis. BMC Psychiatry. 11(1). 6–6. 18 indexed citations

12.

Broder, Michael S., John A. Bates, Yonghua Jing, et al.. (2011). Association between second-generation antipsychotic medication half-life and hospitalization in the community treatment of adult schizophrenia. Journal of Medical Economics. 15(1). 105–111. 10 indexed citations

13.

Broder, Michael S., Timothy Juday, Eunice Chang, Yonghua Jing, & Tanya G. K. Bentley. (2011). Using Administrative Claims Data to Estimate Virologic Failure Rates among Human Immunodeficiency Virus–Infected Patients with Antiretroviral Regimen Switches. Medical Decision Making. 32(1). 118–131. 2 indexed citations

14.

Jing, Yonghua, Stephen S. Johnston, Robert Fowler, et al.. (2011). Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder. Journal of Medical Economics. 14(6). 777–786. 6 indexed citations

15.

Gibson, Teresa B., Yonghua Jing, Ginger Smith Carls, et al.. (2010). Cost burden of treatment resistance in patients with depression.. PubMed. 16(5). 370–7. 126 indexed citations

16.

Jing, Yonghua, et al.. (2009). Use pattern and off-label use of atypical antipsychotics in bipolar disorder, 1998-2002.. PubMed. 2(4). 184–91. 2 indexed citations

17.

Jing, Yonghua, et al.. (2009). Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone. Journal of Medical Economics. 12(2). 104–113. 19 indexed citations

18.

Kim, Edward, et al.. (2009). Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: A retrospective claims database analysis. Clinical Therapeutics. 31(4). 836–848. 14 indexed citations

19.

Guo, Jeff J., et al.. (2008). Principal components analysis of drug expenditure and utilisation trends for major therapeutic classes in US Medicaid programmes. Journal of Medical Economics. 11(4). 671–694. 6 indexed citations

20.

Jing, Yonghua, Patricia E. Klein, Christina M.L. Kelton, Xing Li, & Jeff J. Guo. (2007). Utilization and spending trends for antiretroviral medications in the U.S. Medicaid program from 1991 to 2005. AIDS Research and Therapy. 4(1). 22–22. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact